NCT00176046View on ClinicalTrials.gov

Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study

PHASE4CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

May 31, 1999

Primary Completion Date

June 30, 2009

Study Completion Date

July 31, 2009

Conditions
Metastatic Breast Cancer
Interventions
DRUG

viscum album pini

s.c. injection of 0,001-20 mg 3 times per week

DRUG

viscum album pini

s.c. injection 0,001-20 mg 3 times per week

Trial Locations (1)

D-69120

Department of Complementary and Integrative Medicine, Heidelberg

All Listed Sponsors
collaborator

Verein für Krebsforschung, Arlesheim, Swizzerland

UNKNOWN

collaborator

Weleda AG, D-73525 Schwäbisch Gmünd

UNKNOWN

lead

Heidelberg University

OTHER

NCT00176046 - Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study | Biotech Hunter | Biotech Hunter